Rankings
▼
Calendar
AMRX Q2 2022 Earnings — Amneal Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMRX
Amneal Pharmaceuticals, Inc.
$4B
Q2 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$559M
+4.5% YoY
Gross Profit
$201M
35.8% margin
Operating Income
-$199M
-35.5% margin
Net Income
-$121M
-21.6% margin
EPS (Diluted)
$-0.80
QoQ Revenue Growth
+12.4%
Cash Flow
Operating Cash Flow
-$126M
Free Cash Flow
-$143M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$4.0B
Total Liabilities
$3.9B
Stockholders' Equity
$280M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$559M
$535M
+4.5%
Gross Profit
$201M
$212M
-5.6%
Operating Income
-$199M
$67M
-395.9%
Net Income
-$121M
$15M
-931.3%
Revenue Segments
Generics Segment
$365M
65%
Av K A R E Segment
$97M
17%
Amneal Specialty Pharma Segment
$97M
17%
← FY 2022
All Quarters
Q3 2022 →